- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04014088
Helmet CPAP vs Facemask CPAP in ACPE (hCPAP vs fCPAP)
A Randomized Controlled Trial Comparing Helmet Continuous Positive Airway Pressure (CPAP) vs Facemask CPAP for Treatment of Acute Cardiogenic Pulmonary Edema In The Emergency Department
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Non-invasive ventilation(NIV) has different types of interfaces that had been used in acute cardiogenic pulmonary edema. The appropriate interface is necessary to provide comfort and lead to the success of NIV.
NIV delivered via facemask had been used widely. However, it was associated with leaks and discomfort to the patient.
Helmet continuous positive airway pressure (hCPAP) is an NIV interface that allows the provision of high airway pressures with a minimal leak.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- All patients aged more than 18 years old presented with acute cardiogenic pulmonary oedema
Exclusion Criteria:
- Age less than 18 years old
- Low GCS (less than 8), altered mental status
- Hemodynamic instability, impending cardiopulmonary arrest
- Use of vasopressors, inotropes
- Exacerbation of asthma or chronic respiratory failure
- Urgent need for endotracheal intubation
- Absence of airway protective gag reflex
- Elevated intracranial pressure
- Tracheostomy
- Pregnant
- Upper airway obstruction
- Injuries or surgery to head and neck less than 6 months upon presentation
- Claustrophobia
- Blind or poor vision
- Medico-legal related cases
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: helmet CPAP
helmet CPAP administer to patient diagnosed as acute cardiogenic pulmonary edema
|
The patient presented with Acute Cardiogenic Pulmonary Edema will be randomized into either helmet CPAP or facemask CPAP.
|
|
Active Comparator: facemask CPAP
facemask CPAP administer to patient diagnosed as acute cardiogenic pulmonary edema
|
The patient presented with Acute Cardiogenic Pulmonary Edema will be randomized into either helmet CPAP or facemask CPAP.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Respiratory Rate
Time Frame: 1 hour
|
Respiratory rate change post intervention
|
1 hour
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Heart Rate
Time Frame: 1 hour
|
Heart rate change post intervention
|
1 hour
|
|
Partial Pressure of Arterial Oxygen Level
Time Frame: 1 hour
|
Partial arterial oxygen level post intervention
|
1 hour
|
|
Ratio Of Partial Pressure Arterial Oxygen And Fraction Of Oxygen
Time Frame: 1 hour
|
Partial arterial oxygen/fraction of oxygen ratio change post intervention
|
1 hour
|
|
Dyspnea Scale
Time Frame: 1 hour
|
Dyspnea scale improvement post intervention.Dyspnea scale measured using an unmarked 100mm VAS card that had mark with "I can breathe normally", at one end correspond to patients' normal baseline breathing which score "0" and on the other end "I can't breathe at all", which score "100" represent the worst difficulty perceived by patients.
|
1 hour
|
|
Partial Pressure of Arterial Carbon Dioxide level
Time Frame: 1 hour
|
Partial Pressure of Arterial Carbon Dioxide level change post intervention.
|
1 hour
|
|
Rate of Intubation
Time Frame: 1 hour
|
Intubation rate post intervention
|
1 hour
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Adi Osman, Emergency Department, Hospital Raja Permaisuri Bainun
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- NMRR-14-1894-21782 (IIR).
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Acute Cardiogenic Pulmonary Edema
-
Beni-Suef UniversityCompletedCardiogenic Pulmonary Edema | Differentiation | Diagnostic Biomarker | Clara Cell Protein | Non-Cardiogenic Pulmonary EdemaEgypt
-
Beijing Chao Yang HospitalCompletedAcute Cardiogenic Pulmonary EdemaChina
-
Assiut UniversityCompletedAcute Cardiogenic Pulmonary EdemaEgypt
-
University Hospital, ToulouseCompleted
-
University Hospital, RouenCompletedSevere Acute Cardiogenic Pulmonary EdemaFrance
-
RWTH Aachen UniversityPhilips Technology Aachen GermanyUnknownAcute Decompensated Heart Failure (ADHF) | Acute Cardiogenic Pulmonary Edema (ACPE)Germany
-
University Hospital, MontpellierFisher and Paykel HealthcareCompletedHypercapnic Respiratory Failure | Acute Cardiogenic Pulmonary EdemaFrance
-
University of MonastirCompleted
-
Hopital LariboisièreCompleted
-
Centre Hospitalier Universitaire de la RéunionRecruiting
Clinical Trials on hCPAP vs fCPAP
-
Hospital Raja Permaisuri BainunCompletedCardiogenic Pulmonary EdemaMalaysia
-
Göteborg UniversityNot yet recruiting
-
Verastem, Inc.CompletedNon Small Cell Lung Cancer | KRAS Activating MutationUnited States, Spain, France, Germany, Italy
-
Northwestern UniversityNational Institute on Aging (NIA)CompletedCognitive Impairment | Alzheimer DiseaseUnited States
-
Verastem, Inc.GOG Foundation; European Network of Gynaecological Oncological Trial Groups...Active, not recruitingOvarian Cancer | Low Grade Ovarian Serous AdenocarcinomaSpain, United States, Belgium, United Kingdom, France, Canada, Italy
-
University Children's Hospital, ZurichCompletedTime Until Identification of Defined ParameterSwitzerland
-
Weill Medical College of Cornell UniversityWithdrawn
-
Gruppo Italiano Studio LinfomiCompleted
-
University of PennsylvaniaNational Institute of Mental Health (NIMH)CompletedMemory ConsolidationUnited States
-
Hospital Universitari de BellvitgeCompletedMorbid Obesity | Bariatric SurgerySpain